Neha Krishnamohan - Jun 7, 2021 Form 3 Insider Report for Kinnate Biopharma Inc. (KNTE)

Signature
/s/ Mark A. Meltz, attorney-in-fact
Stock symbol
KNTE
Transactions as of
Jun 7, 2021
Transactions value $
$0
Form type
3
Date filed
6/8/2021, 08:30 PM
Next filing
Feb 15, 2022

No securities are beneficially owned.